Research Articles | Page 2 | Aplastic Anemia & MDS International Foundation

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
When is iron overload deleterious, and when and how should iron chelation therapy be administered in myelodysplastic syndromes? Dec 2013 Best Pract Res Clin Haematol myelodysplastic syndromes (MDS)
Very Severe Aplastic Anemia During Treatment With Doxycycline Oct 2016 Am J Ther. aplastic anemia
Venetoclax and Hypomethylating Agents (HMAs) Induce High Response Rates in MDS, Including Patients After HMA Therapy Failure Jul 2020 Blood Advances myelodysplastic syndromes (MDS)
Variations in erythropoiesis-stimulating agent administration in transfusion-dependent myelodysplastic syndromes impact response Mar 2015 Leuk Res myelodysplastic syndromes (MDS)
Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodyspla Feb 2015 Leukemia myelodysplastic syndromes (MDS)
Validation of the revised international prognostic scoring system in treated patients with myelodysplastic syndromes. Apr 2013 Am J Hematol myelodysplastic syndromes (MDS)
Validation of a Prognostic Model and the Impact of Mutations in Patients With Lower-Risk Myelodysplastic Syndromes Aug 2012 J Clin Oncol myelodysplastic syndromes (MDS)
Use of newer prognostic indices for patients with myelodysplastic syndromes in the low and intermediate-1 risk categories: a population-based study Jun 2015 Lancet Haematol myelodysplastic syndromes (MDS)
Use of Immunosuppressive therapy for management of myelodysplastic syndromes: a systematic review and meta-analysis Apr 2019 Haemotologica myelodysplastic syndromes (MDS)
Use of eltrombopag for treatment of myelodysplastic syndromes Mar 2017 Lancet Haematol myelodysplastic syndromes (MDS)